Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Phase I/II Trial of Gabapentin Plus Ketamine for Prevention and Treatment of Acute and Chronic Pain in Locally Advanced Head and Neck Cancer Patients Undergoing Primary or Adjuvant Chemoradiation


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05156060

Organisation Name: Vanderbilt-Ingram Cancer Center

Overal Status: Recruiting

Start Date: April 1, 2022

Last Update: January 27, 2022

Lead Sponsor: Dianne Lou

Brief Summary: This is a study to establish a safe and feasible dose for prophylactic use of a combination of gabapentin and ketamine in head and neck cancer patients undergoing chemoradiation.

Conditions:
  • Head and Neck Cancer
  • Locally Advanced Head and Neck Carcinoma


Total execution time in seconds: 0.26963496208191